Rishiroop
- Market cap
- ₹ 104 Cr.
- P/E
- 10.1x
- P/B
- 0.79x
- 52-week range
- 71.5 – 146.6
- ROE
- 3%
- ROCE
- 5%
- Dividend yield
- 1.3%
- Debt / equity
- 0
- Sector
- Industrial Products
- Industry
- Rubber
- Listed on
- BSE
About
Rishiroop Limited is an India-based company, which is engaged in manufacturing of polyvinyl chloride-acrylonitrile butadiene rubber (PVC-NBR) blends and trading of polymers. The Company manufactures both chlorinated rubber (sold under its brand name Chlorub) and NBR-PVC polymer blends (sold under its brands Vinoprene and Vinoplast) in India. It is engaged in single segment, which is Polymers & Compound. Its products include poly-butadiene rubber, polychloroprene rubber, styrene butadiene rubber (emulsion/solution), thermoplastic polyolefins, carbon blacks, functional fillers, homogenizing agents, styrenated phenol, naphthenic oils, polymeric plasticizers, thermoplastic vulcanizates and acrylonitrile butadiene co-polymer (NBR) latex. The Company caters to the construction, household/industrial cleaning, inks, leather auxiliaries, mining, oil and gas, paper, personal care, pharmaceuticals, plastics, polyurethanes and textiles industries. Its products are exported across the world.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Rubber: 14 companies →Rishiroop against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)10.1 against a typical 22.1: cheaper than most peers (1st = cheapest).1st of 14
- Sales growth+38.9% against a typical +27.2% from a year earlier.4th of 12
- Profit growth+44.4% against a typical +44.4% from a year earlier.6th of 11
- Share price, 3 months+24.8% against a typical −12.2%.3rd of 14
- Size₹ 103.7 Cr. market value against a typical ₹ 269.7 Cr. (1st = largest).11th of 14
Financials
Standalone figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 20 | 20 | 20 | 18 | 21 | 17 | 19 | 18 | 18 | 15 | 21 | 25 |
| Expenses | 18 | 18 | 18 | 17 | 19 | 16 | 17 | 16 | 16 | 15 | 19 | 19 |
| Operating Profit | 2 | 2 | 2 | 1 | 2 | 1 | 2 | 1 | 1 | 0 | 2 | 6 |
| OPM % | 9% | 12% | 8% | 6% | 10% | 4.2% | 9% | 8% | 7% | 2.6% | 10% | 23% |
| Other Income | 4 | 7 | 4 | 10 | 7 | −3 | −4 | 9 | −1 | 4 | −8 | 10 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 6 | 9 | 6 | 11 | 9 | −3 | −2 | 10 | 0 | 4 | −6 | 16 |
| Tax % | 21% | 16% | 7% | 22% | 18% | −9% | 2% | 15% | 45% | 19% | −10% | 19% |
| Net Profit | 4 | 8 | 5 | 8 | 7 | −3 | −2 | 9 | 0 | 3 | −6 | 13 |
| EPS in Rs | 4.91 | 8.38 | 5.71 | 8.92 | 8.05 | −2.74 | −2.61 | 9.46 | 0.24 | 3.74 | −6.13 | 13.84 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 7%
- 5 Years
- 6%
- 3 Years
- −7%
- TTM
- 7%
- 10 Years
- 16%
- 5 Years
- −18%
- 3 Years
- −18%
- TTM
- −4%
- 10 Years
- 12%
- 5 Years
- 2%
- 3 Years
- −6%
- TTM
- —
- 10 Years
- 9%
- 5 Years
- 9%
- 3 Years
- 7%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Rishiroop | ₹ 118.55 | ₹ 104 Cr. | 10.1x | 0.8x | 3% | — |
| Gujarat Fluorochemicals | ₹ 4,241.25 | ₹ 47,986 Cr. | 86x | 6.4x | 7.7% | 11.5% |
| DCM Shriram | ₹ 962.10 | ₹ 14,996 Cr. | 5.7x | 2.1x | 11.6% | 6% |
| Supreme Petrochem | ₹ 710.10 | ₹ 13,338 Cr. | 40.5x | 5.8x | 14.3% | 6.1% |
| Shaily Engineering Plastics | ₹ 2,953.20 | ₹ 13,594 Cr. | 77.3x | 18.2x | 26.9% | 17.2% |
| Kama Holdings | ₹ 2,120.00 | ₹ 6,803 Cr. | 8.7x | 1.1x | 12.2% | 11.6% |
Management
- Suresh H. Khilnani
- Chief Financial Officer
- Agnelo Anthony Fernandes
- Compliance Officer, Company Secretary
- Aditya Arvind Kapoor
- Managing Director, Executive Director
Prices are delayed and for information only. Nothing on this page is investment advice.